同病性痴呆症和慢性病的趋势
Milda R Saunders1,2, Mingyu Qi3, Elbert S Huang4,5,3
1Section of General Internal Medicine, Department of Medicine, University of Chicago Medicine, Chicago, IL, USA. msaunders@uchicago.edu.
Journal of general internal medicine
|January 14, 2025
概括
患有慢性病 (CKD) 和阿尔茨海默病及相关痴呆症 (ADRD) 的老年人数正在增加,特别是在黑人和西班牙裔人口中. 针对CKD进展的干预措施可能有助于延迟ADRD发病.
科学领域:
- 老年学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
背景情况:
- 在医疗保险受益者中,对慢性病 (CKD) 和阿尔茨海默氏症和相关痴呆症 (ADRD) 的同时发生的理解有限.
- 调查这种双重诊断人口的特征和趋势对于公共卫生倡议至关重要.
研究的目的:
- 为了估计医疗保险受益者患有并发性CKD和ADRD的患病率,增长和人口统计特征.
- 从2011年到2019年分析CKD和ADRD患病率的趋势.
主要方法:
- 使用的医疗保险服务费 (FFS) 受益人数据从2011-2019年.
- 使用慢性病数据仓库 (CCW) 指标识别了患有CKD和ADRD的个体.
- 分析了共患病状况中的患病率,增长和种族种族差异.
主要成果:
- 慢性脏病的患病率从17.5%增加到27.9%,而ADRD的患病率在2011年至2019年间从13.3%略有下降到12.5%.
- 同病性CKD和ADRD的患病率从4.4%上升到6.3% (1.72万老年人).
- 黑人和西班牙裔个体表现出共患性CKD和ADRD的最高患病率,在以前被诊断为ADRD的人中,比例越来越高.
结论:
- 在医疗保险受益者中,CKD和ADRD的同时发生率正在上升,尽管ADRD总体患病率下降.
- 共同的风险因素表明,CKD干预措施可能会延迟ADRD的发病.
- 对受影响患者来说,临床和政策的重点是同时管理这两种疾病,这是必不可少的.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
52
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
52
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
01:26Alzheimer's Disease: Overview
440
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
440
01:30Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
89
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
89
01:06Renal Drug Clearance: Overview
112
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
112